Research of the Pharmacokinetics and Pharmacodynamics of Torasemide in the Treatment of Children Patients with Acute Heart Failure

Xiao Qun Wen; Yang Long; He Xiang Ying; Li Qi; You Jun

Article Contents

Article Navigation > Journal of Kunming Medical University > 2018 > 39(05): 66-69

Xiao Qun Wen , Yang Long , He Xiang Ying , Li Qi , You Jun . Research of the Pharmacokinetics and Pharmacodynamics of Torasemide in the Treatment of Children Patients with Acute Heart Failure[J]. Journal of Kunming Medical University, 2018, 39(05): 66-69.

Citation:

Xiao Qun Wen , Yang Long , He Xiang Ying , Li Qi , You Jun . Research of the Pharmacokinetics and Pharmacodynamics of Torasemide in the Treatment of Children Patients with Acute Heart Failure[J]. Journal of Kunming Medical University, 2018, 39(05): 66-69.

Citation:

Xiao Qun Wen , Yang Long , He Xiang Ying , Li Qi , You Jun . Research of the Pharmacokinetics and Pharmacodynamics of Torasemide in the Treatment of Children Patients with Acute Heart Failure[J]. Journal of Kunming Medical University, 2018, 39(05): 66-69.

PDF( 187 KB)

Research of the Pharmacokinetics and Pharmacodynamics of Torasemide in the Treatment of Children Patients with Acute Heart Failure

Funds:

基金：云南省卫生科技计划研究基金资助项目 (2014NS182);

Received Date: 2018-02-14

Abstract

Abstract

Objective To investigate the pharmacokinetics and pharmacokinetics of torsemide in children with acute heart failure.Me thods Ninety cases of children with acute heart failure patients were randomly divided into three groups which were given different intravenous therapy doses of torsemide. Our goal is to provide the basis for clinical rational therapy by analyzing parameter of the pharmacokinetics and pharmacokinetics of torsemide which is acquired by detecting plasma concentration of torsemide with liquid chromatography and tandem mass spectrometry after a one-time medication. Re s ult Average pharmacokinetic parameters of the three groups in addition to the peak concentration (Cmax) and medication in the area under the curve (AUC0-16) are different (P < 0.01) , the rest of the pharmacokinetic parameters had no significant difference (P > 0.05) . The 24 hours urine volume of the experimental group Ⅱ and the experimental group Ⅲ were obviously higher than that of the experimental group Ⅰ, so the difference was statistically significant (P < 0.01) .The 24 hours urine volumes between the experimental group Ⅱ and the experimental group Ⅲ were no significant difference (P > 0.05) .There was no significant change in blood pressure, weight, abdominal girth, blood potassium, blood sodium and blood chlorine in the three dose groups compared with those before the treatment.There was no significant difference between the three groups (P>0.05) .Conclus ionThe children with acute heart failure were well tolerated with torsemide.The recommended dose of torsemide is 1.0 mg/ (kg.d) in the treatment of acute heart failure in children, based on pharmacokinetic and pharmacodynamic characteristics.
- Acute heart failure,
- Torasemide,
- Blood concentration,
- Children,
- Pharmacokinetics,

FullText(HTML)

References(12)

References

[1]李燕萍, 郝应禄, 陈利, 等.射血分数保留的心力衰竭临床特征[J].昆明医科大学学报, 2016, 37 (4) :107-111.
[2]彭妍钰, 潘蓉蓉.托拉塞米治疗充血性心力衰竭的安全性及对心功能的影响[J].中国医药导报, 2011, 8 (15) :78-79.
[3]钟飞, 李伟, 许先进.31例托拉塞米注射剂治疗急性左心衰竭的临床分析[J].中国民康医学, 2012, 24 (13) :1537-1538.
[4]刘世秀.托拉塞米治疗心力衰竭的临床效果分析[J].现代诊断与治疗, 2014, 25 (19) :4436-4437.
[5]宋菲, 张冬颖, 刘剑.利尿剂在心力衰竭中的治疗进展[J].医学综述, 2015, 21 (8) :1427-1429.
[6]肖群文, 杨龙, 李琪, 等.托拉塞米治疗儿童急性心力衰竭的药动学和药效学研究进展[J].医学综述, 2017, 23 (11) :2236-2244.
[7] 胡亚美, 江载芳.诸福棠实用儿科学[M].第7版.北京:人民卫生出版社, 2006:1510-1525.
[8]	[8] SCHWARTZ S, BRATER D C, PPIMD D, et al.Bioavailability, pharmacokinetics and pharmacodynamics of torasemide in patients with cirrhosis[J].Clin Pharmacol Ther, 1993, 54 (1) :90-97.
[9]黄浙勇, 钱菊英, 葛均波.心力衰竭治疗中袢利尿剂的合理应用[J].中国临床医学, 2011, 18 (6) :897-898.
[10]刘文德.托拉塞米注射液治疗急性左心衰竭患者疗效观察[J].黑龙江医药, 2016, 29 (2) :274-276.
[11]	[11] ACHHAMMER I, METZ P.Low dose loop diuretics in essential hypertension:experience with torasemide[J].Drugs, 1991, 41 (3) :80-91.
[12]龙岩, 周宗华, 周承操.托拉塞米与呋塞米对慢性心力衰竭治疗效果的比较[J].中国医药科学, 2015, 5 (9) :85-87.

Relative Articles(20)

Relative Articles

[1]	Haoran XING, Xi ZHANG, Yingying ZHANG, Tianhao BAO. Advancements in the Clinical Use of Antidepressants for Adolescent Depression. Journal of Kunming Medical University, 2024, 45(7): 168-176. doi: 10.12259/j.issn.2095-610X.S20240725
[2]	Wei HU, Jinnan LI, Wei YANG, Li SU, Zhuo YU, Zhisong CHEN. Interventional Treatment of Muscular Ventricular Septal Defect in Children. Journal of Kunming Medical University, 2024, 45(3): 48-53. doi: 10.12259/j.issn.2095-610X.S20240307
[3]	Haijin LI, Huiyuan LI, Xinmiao LIU, Yue TIAN, Na LI, Zhengcheng DUAN, Xin TIAN. Clinical Features and Prognosiss of Pediatric Acute Lymphoblastic Leukemia with Hyperleukocytosis. Journal of Kunming Medical University, 2024, 45(7): 105-112. doi: 10.12259/j.issn.2095-610X.S20240716
[4]	Yaling ZHAO, Kun WU, Rong HUANG, Genya HE, Zhenbo DING, Caiying ZHANG. Establishment and Significance of Screening System for Acute Leukemia in Children Based on Detection of TEL-AML1 Fusion Gene in Neonatal Cord Blood. Journal of Kunming Medical University, 2023, 44(1): 54-58. doi: 10.12259/j.issn.2095-610X.S20230126
[5]	Ling ZHAO, Shulan JIAO, Yongyu SI, Liu YANG, Yinghui BU. Pharmacokinetic Study of Dexmedetomidine in Patients with Different Degrees of Burn. Journal of Kunming Medical University, 2023, 44(7): 100-104. doi: 10.12259/j.issn.2095-610X.S20230725
[6]	Yun-li YANG, Na LI, Heng LI, Jun-zhen SHI, Zhi-gui LI. Effects of Dexmedetomidine on the Incidence of Emergence Delirium after General Anesthesia in Pediatric Patients Undergoing Hip Surgery. Journal of Kunming Medical University, 2021, 42(2): 108-112. doi: 10.12259/j.issn.2095-610X.S20210223
[7]	Yang LI, Hua HE, Yan-ling ZHANG, Ying HUANG, Jun-long WANG. Changes of Rifampicin Concentration in Cerebrospinal Fluid of Patients with Tuberculous Meningoencephalitis. Journal of Kunming Medical University, 2021, 42(7): 110-114. doi: 10.12259/j.issn.2095-610X.S20210718
[8]	Juan LI, Jun ZHANG, Qiao-ling ZHENG, Pu-qiong FENG, Jin HE. Analysis of Monitoring Results and Influencing Factors of Vancomycin Blood Concentration in Neurosurgery Department. Journal of Kunming Medical University, 2021, 42(6): 110-114. doi: 10.12259/j.issn.2095-610X.S20210614
[9]	Feng YUANG, Shu-lan JIAO, Rui CHEN, Bing-bing XIANG, Yong-yu SI. Pharmacokinetics of Etomidate in Patients with Different Degrees of Burn. Journal of Kunming Medical University, 2021, 42(6): 94-97. doi: 10.12259/j.issn.2095-610X.S20210637
[10]	Li TAN, Ming LI, Yu-xing SUN, Zhen ZHANG, Zheng-yan GAN. Molecular Epidemiology of Human Rhinovirus in 2 260 Children with Acute Lower Respiratory Tract Infection. Journal of Kunming Medical University, 2020, 41(12): 119-122. doi: 10.12259/j.issn.2095-610X.S20201233
[11]	Zhang Ling , Huang Chun Jiang , Wang Yi , Tan Ling Xiang . . Journal of Kunming Medical University, 2019, 40(01): 78-81.
[12]	Duan Er Yun , Jiao Shu Lan , Yang Jian . . Journal of Kunming Medical University, 2018, 39(10): 79-83.
[13]	Sun Jian Ming , Dong Fang . Adverse Reactions in Children with Acute Lymphoblastic Leukemia after Chemotherapy. Journal of Kunming Medical University, 2017, 38(10): 107-111.
[14]	Yang Jun Jun , Hu Xi Chi , Yan Zi He . . Journal of Kunming Medical University, 2017, 38(03): 119-122.
[15]	Qi Zhi Ye . Comparative Analysis of 2000~2010 Epidemiological Survey of Childhood Asthma in Kunming City， China. Journal of Kunming Medical University,
[16]	He Cheng Lu . . Journal of Kunming Medical University,
[17]	Li Xiu Yun . . Journal of Kunming Medical University,
[18]	Zheng Qiao Ling . . Journal of Kunming Medical University,
[19]	. Determination of Concentration of 5-Fluorouraci in Blood of Cancer Patients by HPLC. Journal of Kunming Medical University,
[20]	. Measurement of Plasma Concentration and Pharmacokinetic Parameters of Febuxostat in Mice. Journal of Kunming Medical University,